| Historiographs |
Grand Totals: LCS 522, GCS 36525 Collection span: 1924 - 2007 | |
| Title Word List (1340) i Word count: 2848, All words count: 4296 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 801 | HEPTAD | 1 | 0 | 13 |
| 802 | HUMAN-LEUKOCYTE | 1 | 0 | 13 |
| 803 | KILODALTON | 1 | 3 | 13 |
| 804 | LOCAL | 1 | 1 | 13 |
| 805 | OCEANIC | 2 | 0 | 13 |
| 806 | ONCOGENES | 2 | 2 | 13 |
| 807 | PREDICTION | 2 | 1 | 13 |
| 808 | SIGN | 1 | 1 | 13 |
| 809 | SPECULATIONS | 1 | 0 | 13 |
| 810 | TEMPLATES | 1 | 1 | 13 |
| 811 | THYMUS-CELL | 1 | 2 | 13 |
| 812 | TIME | 1 | 0 | 13 |
| 813 | V-HA-RAS | 1 | 2 | 13 |
| 814 | V-MYC | 1 | 2 | 13 |
| 815 | ACCURACY | 1 | 5 | 12 |
| 816 | COLLOIDAL | 1 | 3 | 12 |
| 817 | CONTAINERS | 1 | 0 | 12 |
| 818 | DNA-ASSOCIATED | 1 | 0 | 12 |
| 819 | EFFECTS | 2 | 0 | 12 |
| 820 | ESTIMATION | 1 | 3 | 12 |
| 821 | HUMAN-LYMPHOCYTE | 2 | 2 | 12 |
| 822 | INFLUENZA-VIRUS | 1 | 2 | 12 |
| 823 | MAPS | 2 | 1 | 12 |
| 824 | MEASUREMENT | 1 | 5 | 12 |
| 825 | METHODS | 2 | 3 | 12 |
| 826 | MUTUAL | 1 | 3 | 12 |
| 827 | MYCOBACTERIUM-BOVIS | 3 | 1 | 12 |
| 828 | NON-RIGID | 1 | 0 | 12 |
| 829 | PHYSICS | 3 | 0 | 12 |
| 830 | PLACE | 1 | 3 | 12 |
| # | Word | Recs | TLCS | TGCS |
| 831 | SHRINKAGE | 1 | 5 | 12 |
| 832 | SIZE | 1 | 3 | 12 |
| 833 | ALPHA | 2 | 0 | 11 |
| 834 | ANOMALOUS | 1 | 0 | 11 |
| 835 | BONDING | 1 | 1 | 11 |
| 836 | ELECTRONS | 1 | 1 | 11 |
| 837 | FORM | 2 | 2 | 11 |
| 838 | ORDER-DISORDER | 1 | 0 | 11 |
| 839 | PRODUCE | 1 | 6 | 11 |
| 840 | PROGRAM | 2 | 1 | 11 |
| 841 | RIBONUCLEASE-II | 1 | 2 | 11 |
| 842 | STABILITY | 1 | 0 | 11 |
| 843 | TRANSITIONS | 1 | 0 | 11 |
| 844 | UNIVERSAL | 1 | 6 | 11 |
| 845 | YEAST | 1 | 6 | 11 |
| 846 | ACTIVITIES | 1 | 0 | 10 |
| 847 | C-MYC | 1 | 0 | 10 |
| 848 | GENOMICS | 3 | 1 | 10 |
| 849 | ISOLATED | 1 | 2 | 10 |
| 850 | NATIONAL-INSTITUTES-OF-HEALTH | 1 | 1 | 10 |
| 851 | OXIDATION | 1 | 0 | 10 |
| 852 | PDGFRB | 1 | 0 | 10 |
| 853 | PROMOTER-BINDING | 1 | 0 | 10 |
| 854 | SELECTION | 1 | 1 | 10 |
| 855 | SEPARABLE | 1 | 0 | 10 |
| 856 | SPONTANEOUS | 2 | 0 | 10 |
| 857 | TARGET | 1 | 1 | 10 |
| 858 | TEMPLATE | 1 | 2 | 10 |
| 859 | 12Q13.13 | 1 | 2 | 9 |
| 860 | ANTIBODY-SYNTHESIS | 1 | 1 | 9 |
| # | Word | Recs | TLCS | TGCS |
| 861 | ANTIGEN-INDUCED | 1 | 0 | 9 |
| 862 | APC | 1 | 2 | 9 |
| 863 | BOVIS | 1 | 0 | 9 |
| 864 | COMMUNICATION | 1 | 1 | 9 |
| 865 | DAY | 1 | 0 | 9 |
| 866 | DILUTION | 1 | 0 | 9 |
| 867 | DOSE | 1 | 2 | 9 |
| 868 | EMERGENT | 1 | 2 | 9 |
| 869 | FLAKY | 2 | 1 | 9 |
| 870 | GENERATED | 1 | 2 | 9 |
| 871 | HUMORAL-FACTORS | 1 | 1 | 9 |
| 872 | HYBRIDIZATION | 1 | 2 | 9 |
| 873 | IL-4 | 1 | 2 | 9 |
| 874 | INFLUENCED | 1 | 2 | 9 |
| 875 | INSITU | 1 | 2 | 9 |
| 876 | ITG-BETA-7 | 1 | 2 | 9 |
| 877 | LIMITING | 1 | 0 | 9 |
| 878 | LUPUS-ERYTHEMATOSUS | 1 | 1 | 9 |
| 879 | LYMPHOPOIESIS | 1 | 0 | 9 |
| 880 | MYCOBACTERIAL | 2 | 2 | 9 |
| 881 | NONISOTOPIC | 1 | 2 | 9 |
| 882 | NOTE | 2 | 0 | 9 |
| 883 | PHENOTYPE | 1 | 2 | 9 |
| 884 | PPD | 1 | 2 | 9 |
| 885 | PRESENCE | 1 | 2 | 9 |
| 886 | PRESENTATION | 1 | 2 | 9 |
| 887 | PRESENTING | 1 | 2 | 9 |
| 888 | PROBLEMS | 1 | 0 | 9 |
| 889 | PROGENITORS | 1 | 0 | 9 |
| 890 | PSEUDO-CRYSTALLINE | 1 | 0 | 9 |
| # | Word | Recs | TLCS | TGCS |
| 891 | SCIENTIST | 1 | 0 | 9 |
| 892 | SENSITIVITY | 1 | 0 | 9 |
| 893 | SKIN | 2 | 1 | 9 |
| 894 | SUPPLY | 1 | 0 | 9 |
| 895 | SYSTEMIC | 1 | 1 | 9 |
| 896 | VIVO | 1 | 2 | 9 |
| 897 | 1-RESTRICTED | 1 | 0 | 8 |
| 898 | 19-KD | 1 | 0 | 8 |
| 899 | AMINO-TERMINAL | 2 | 0 | 8 |
| 900 | ASPECTS | 1 | 0 | 8 |
| 901 | BARRIERS | 1 | 1 | 8 |
| 902 | BCG-VACCINATED | 1 | 1 | 8 |
| 903 | BIOINFORMATICS | 1 | 0 | 8 |
| 904 | BIOPSIES | 1 | 1 | 8 |
| 905 | CDNAS | 2 | 0 | 8 |
| 906 | COMMENT | 1 | 0 | 8 |
| 907 | CYTOKINE | 2 | 1 | 8 |
| 908 | DATA-MANAGEMENT | 1 | 0 | 8 |
| 909 | DELTA-SUBUNIT | 3 | 0 | 8 |
| 910 | DIFFERING | 2 | 0 | 8 |
| 911 | DIMENSION | 1 | 0 | 8 |
| 912 | DR4 | 1 | 0 | 8 |
| 913 | EIF-2B | 2 | 0 | 8 |
| 914 | ELIMINATE | 1 | 0 | 8 |
| 915 | END | 2 | 0 | 8 |
| 916 | EVENTS | 1 | 0 | 8 |
| 917 | GUANINE-NUCLEOTIDE | 2 | 0 | 8 |
| 918 | HIGH-THROUGHPUT | 1 | 0 | 8 |
| 919 | IMMUNODOMINANT | 1 | 0 | 8 |
| 920 | ISOFORMS | 2 | 0 | 8 |
| # | Word | Recs | TLCS | TGCS |
| 921 | KINETICS | 1 | 0 | 8 |
| 922 | LOOKING | 1 | 0 | 8 |
| 923 | LYMPHOCYTE-RESPONSES | 1 | 0 | 8 |
| 924 | MICROENVIRONMENTS | 1 | 0 | 8 |
| 925 | PREDICTS | 2 | 0 | 8 |
| 926 | PROGRESS | 1 | 1 | 8 |
| 927 | RHEUMATOID-ARTHRITIS | 1 | 0 | 8 |
| 928 | SELF-REACTIVE | 1 | 0 | 8 |
| 929 | SKIN-TEST | 1 | 1 | 8 |
| 930 | SPINE | 1 | 0 | 8 |
| 931 | STRATEGIES | 1 | 1 | 8 |
| 932 | STROMAL | 1 | 0 | 8 |
| 933 | THERMODYNAMICS | 1 | 0 | 8 |
| 934 | TUBERCULIN | 1 | 1 | 8 |
| 935 | VACCINES | 2 | 1 | 8 |
| 936 | AIR | 1 | 0 | 7 |
| 937 | ASCITES | 1 | 0 | 7 |
| 938 | BACTERIAL | 1 | 0 | 7 |
| 939 | CARBONES | 1 | 1 | 7 |
| 940 | CONNEXION | 1 | 0 | 7 |
| 941 | DEN | 1 | 0 | 7 |
| 942 | FOLLOWING | 1 | 0 | 7 |
| 943 | GENE-EXPRESSION | 1 | 0 | 7 |
| 944 | GENETICS | 1 | 0 | 7 |
| 945 | GENETISCHEN | 1 | 0 | 7 |
| 946 | GONIOMETER | 1 | 0 | 7 |
| 947 | GRAPHITISABLES | 1 | 1 | 7 |
| 948 | KINASE-ACTIVITY | 1 | 0 | 7 |
| 949 | LES | 1 | 1 | 7 |
| 950 | LINKAGES | 1 | 0 | 7 |
| # | Word | Recs | TLCS | TGCS |
| 951 | MEDIUM | 1 | 0 | 7 |
| 952 | MOLECULAR-STRUCTURE | 2 | 0 | 7 |
| 953 | MULTIDRUG-RESISTANT | 1 | 0 | 7 |
| 954 | NEONATAL | 1 | 0 | 7 |
| 955 | NON-GRAPHITISABLES | 1 | 1 | 7 |
| 956 | NUCLEIC-ACID | 2 | 0 | 7 |
| 957 | NUCLEIC-ACIDS | 2 | 0 | 7 |
| 958 | PHOSPHOTRIESTER | 1 | 0 | 7 |
| 959 | POLITICS | 2 | 0 | 7 |
| 960 | PUMP | 1 | 0 | 7 |
| 961 | RAIDS | 1 | 0 | 7 |
| 962 | STAGE | 1 | 0 | 7 |
| 963 | TERMINOLOGY | 1 | 0 | 7 |
| 964 | TRANSFER | 1 | 0 | 7 |
| 965 | TYROSINE | 1 | 0 | 7 |
| 966 | UBER | 1 | 0 | 7 |
| 967 | YEAR | 1 | 0 | 7 |
| 968 | 2-DEPENDENT | 1 | 3 | 6 |
| 969 | AMINOBISPHOSPHONATE | 1 | 0 | 6 |
| 970 | AZULENE | 1 | 0 | 6 |
| 971 | BONE-RESORPTION | 1 | 0 | 6 |
| 972 | CALVARIAE | 1 | 0 | 6 |
| 973 | CHROMOSOME | 1 | 2 | 6 |
| 974 | CHROMOSOME-15 | 1 | 1 | 6 |
| 975 | CLONED | 1 | 3 | 6 |
| 976 | COMPONENTS | 1 | 0 | 6 |
| 977 | CONDITIONS | 2 | 0 | 6 |
| 978 | CYTO-TOXIC | 2 | 1 | 6 |
| 979 | DERMAL | 1 | 0 | 6 |
| 980 | DISRUPTED | 1 | 1 | 6 |
| # | Word | Recs | TLCS | TGCS |
| 981 | DISTAL | 1 | 1 | 6 |
| 982 | ESTS | 1 | 0 | 6 |
| 983 | GENERALIZED | 2 | 0 | 6 |
| 984 | GENETIC-MAPPING | 1 | 1 | 6 |
| 985 | I-REGION | 1 | 2 | 6 |
| 986 | IMMUNE-RESPONSE | 1 | 2 | 6 |
| 987 | INOCULATION | 2 | 0 | 6 |
| 988 | INTEGRIN-BETA-7 | 1 | 1 | 6 |
| 989 | INTERLEUKIN-1-INDUCED | 1 | 0 | 6 |
| 990 | LEVELS | 2 | 2 | 6 |
| 991 | LONG-LASTING | 2 | 0 | 6 |
| 992 | LYMPHOID | 1 | 1 | 6 |
| 993 | MAINTAINED | 1 | 3 | 6 |
| 994 | ONTOGENY | 2 | 1 | 6 |
| 995 | PAPILLA | 1 | 0 | 6 |
| 996 | PERIPHERAL | 1 | 1 | 6 |
| 997 | QUANTITATIVE-DETERMINATION | 1 | 2 | 6 |
| 998 | RANGE | 2 | 0 | 6 |
| 999 | RAT | 1 | 0 | 6 |
| 1000 | REFLECTIONS | 1 | 0 | 6 |